Does moxonidine reduce Achilles tendon or musculoskeletal pain in women with polycystic ovarian syndrome? A secondary analysis of a randomised controlled trial

Table 2 MSK and VISA-A scores

Data	Group	Pre-intervention	Post-intervention	2-way ANOVA p-value
MSK score	Placebo	3.2 ± 2.2	2.8 ± 2.8	Group < 0.01* Time-point = 0.11 Group x Time-point = 0.69
MSK score	Moxonidine	2.1 ± 2.2	1.4 ± 2.1	Group < 0.01* Time-point = 0.11 Group x Time-point = 0.69
VISA-A	Placebo	88.2 ± 22.9	92.4 ± 13.5	Group = 0.01* Time-point = 0.29 Group x Time-point = 0.24
VISA-A	Moxonidine	95.3 ± 6.6	95.1 ± 7.8	Group = 0.01* Time-point = 0.29 Group x Time-point = 0.24

ISSN: 1472-6823